Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. 1990

R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
Department of Internal Medicine, Kantonsspital, Liestal, Switzerland.

The purpose of this study was to determine the role of cholecystokinin in the regulation of postprandial pancreatic polypeptide secretion in humans. The pancreatic polypeptide responses to modified sham feeding and gastric instillation of a test meal were first compared with the response to oral ingestion of the same meal. The experiments were repeated under cholinergic (atropine) and cholecystokinin (loxiglumide) blockade. Atropine completely abolished the pancreatic polypeptide response to sham feeding and caused significant reductions after gastric and oral food intake. Loxiglumide, on the other hand, significantly reduced pancreatic polypeptide release to oral food (51% inhibition) without affecting the response to sham feeding. In separate experiments using a duodenal perfusion system, the effects of atropine and loxiglumide on intestinal phase-stimulated pancreatic polypeptide release were examined, and both cholinergic and cholecystokinin blockade induced complete suppression. It was concluded (a) that cholecystokinin is involved in postprandial pancreatic polypeptide response, especially during the intestinal phase stimulation, and (b) that the cholinergic system is crucial and superimposed on cholecystokinin in stimulating pancreatic polypeptide release.

UI MeSH Term Description Entries
D007441 Intubation, Gastrointestinal The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc. Intubation, Nasogastric,Gastrointestinal Intubation,Gastrointestinal Intubations,Intubations, Gastrointestinal,Intubations, Nasogastric,Nasogastric Intubation,Nasogastric Intubations
D008297 Male Males
D010191 Pancreatic Polypeptide A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice. Pancreatic Polypeptide (PP),Pancreatic Polypeptide Hormone,Pancreatic Prohormone
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011377 Proglumide A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Xylamide,Milid,Xilamide
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
May 1991, The Journal of clinical endocrinology and metabolism,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
November 1980, Gastroenterology,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
February 1991, Regulatory peptides,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
April 1995, Pancreas,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
March 1984, Regulatory peptides,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
April 1995, Journal of gastroenterology,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
August 1991, Gastroenterology,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
January 1990, Digestion,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
August 1996, Journal of gastroenterology,
R Meier, and P Hildebrand, and M Thumshirn, and C Albrecht, and B Studer, and K Gyr, and C Beglinger
April 1996, FEBS letters,
Copied contents to your clipboard!